US 8859552
Methods of utilizing arylpiperazine derivatives
granted A61KA61K31/538A61P
Quick answer
US patent 8859552 (Methods of utilizing arylpiperazine derivatives) held by REVIVA PHARMACEUTICALS, INC. expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/538, A61P, A61P25/00, A61P25/18